Fundz

Translate Bio, Inc. reported raising $47.5 Million in an initial SEC Form D filing, from an offering of $47.5 Million

PRIVATEMay 10, 2019

Amount Raised

$47.5 Million

$47.5 Million sold, per SEC Form D (first sale May 10, 2019)

Round Type

Venture

LexingtonBiotechnology

Quick answer

Translate Bio, Inc. raised $47.5 Million in a funding round, dated May 10, 2019. Translate Bio, Inc. is based in Lexington, Massachusetts, United States.

How much did Translate Bio, Inc. raise?
Translate Bio, Inc. raised $47.5 Million in a funding round on May 10, 2019.
What does Translate Bio, Inc. do?
Translate Bio is an mRNA therapeutics company developing potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
Where is Translate Bio, Inc. based and how big is it?
Translate Bio, Inc. is based in Lexington, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Translate Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at Translate Bio, Inc., and when

A new round usually means Translate Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Translate Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Translate Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Translate Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Translate Bio, Inc.

Location

29 HARTWELL AVENUE

Lexington, Massachusetts, United States

About

Translate Bio is an mRNA therapeutics company developing potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Translate Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Translate Bio, Inc.'s next move

See what Strategic adds

Translate Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.